Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA interference targeting factor XI: new and novel approach.

Blood advances·2026
Same author

Antiplatelet Strategies and the Unfinished Story of Thrombosis Prophylaxis.

Circulation research·2026
Same author

Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity.

Journal of thrombosis and thrombolysis·2026
Same author

Complementary Targeted Constructs Factor XI/XIa Inhibition.

Blood advances·2026
Same author

Clinical spectrum and mechanistic insights into cardiotoxicity from cancer therapies.

Journal of thrombosis and thrombolysis·2026
Same author

Innovative strategies for early detection of cardiotoxicity: artificial intelligence and multi-modality collaborative models.

Journal of thrombosis and thrombolysis·2026
Same journal

[Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group. Response].

Revista espanola de cardiologia·2023
Same journal

[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group].

Revista espanola de cardiologia·2023
Same journal

[Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment].

Revista espanola de cardiologia·2022
Same journal

[Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine].

Revista espanola de cardiologia·2022
See all related articles

Related Experiment Video

Updated: Jun 1, 2026

Homing of Hematopoietic Cells to the Bone Marrow
10:40

Homing of Hematopoietic Cells to the Bone Marrow

Published on: March 18, 2009

[Hematologic diseases: from within the heart].

Weixian Xu1, Tracy Y Wang, Richard C Becker

  • 1Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.

Revista Espanola De Cardiologia
|June 7, 2011
PubMed
Summary
This summary is machine-generated.

This review explores non-oncological blood disorders and their significant impact on the cardiovascular system, including arterial circulatory issues like heart attack and stroke. It offers guidance on diagnosis and management for clinical practice.

More Related Videos

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Experiment Videos

Last Updated: Jun 1, 2026

Homing of Hematopoietic Cells to the Bone Marrow
10:40

Homing of Hematopoietic Cells to the Bone Marrow

Published on: March 18, 2009

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Vascular Biology

Context:

  • The cardiovascular and hematological systems are intricately linked, with blood disorders affecting cardiac and vascular structures.
  • Understanding these interfaces is crucial for managing complex patient conditions.

Purpose:

  • To provide a focused overview of non-oncological blood disorders and their impact on the arterial circulatory system.
  • To highlight common phenotypes such as myocardial infarction, ischemic stroke, and peripheral arterial occlusive events.
  • To offer practical guidance on diagnostic testing and management strategies.

Summary:

  • Non-oncological blood disorders significantly influence cardiovascular health, manifesting as myocardial infarction, ischemic stroke, and peripheral arterial occlusive events.
  • The review details the interplay between blood components (cellular and plasma-based) and cardiovascular structures.
  • Venous thromboembolism serves as a clinical example to illustrate diagnostic and management approaches.

Impact:

  • Enhances understanding of the pathophysiology linking blood disorders to arterial circulatory diseases.
  • Provides clinicians with actionable insights for improved diagnosis and management of patients.
  • Contributes to better patient outcomes by addressing the cardiovascular implications of hematological conditions.